A separate study in an ocular hypertensive model demonstrated that VEGF-A promoted RGC neuroprotection via direct activation of the VEGF receptor 2 and signaling through the phosphoinositide-3-kinase/Akt pathway.42 The gene discussed is AKT1; the disease is ocular hypertension.